Search

Physician-scientist Siddhartha Mukherjee, author of The Emperor of All Maladies: A Biography of Cancer, spoke to 2013 graduates of the “tenderness and tension” inherent in scientific discovery.

… Friday, May 17, 2013 Summary Physician-scientist Siddhartha Mukherjee, author of The Emperor of All Maladies: A Biography of Cancer , spoke to 2013 graduates of the “tenderness and tension” inherent in scientific discovery. “Newspapers may bring us news of a scientific-industrial complex that is increasingly

Endometrial cancer is the most common gynecologic malignancy, yet incidence and mortality continue to rise. Advanced and recurrent disease carries a poor prognosis, and there are limited effective treatment options. Gynecologic medical oncologist at Memorial Sloan Kettering Cancer Center, Maria M. Rubinstein, MD, and colleagues conducted a Phase 2 study evaluating the efficacy and safety of PARP inhibitor olaparib plus immunotherapy pembrolizumab in patients with persistent or recurrent CN-H/p53-abnormal endometrial cancer, and concluded that this should be considered a potential treatment option for this population.

… Tuesday, May 5, 2026 Endometrial cancer is the most common gynecologic malignancy, yet incidence and mortality continue to rise. Advanced and recurrent disease carries a poor prognosis, and there are limited effective treatment options. Currently, patients may receive a single-agent therapy, but response

Meet Zhongmin Wang, a fifth-year doctoral student in the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), who has been awarded the 2021 Chairman’s Prize.

… Wednesday, September 22, 2021 Zhongmin Wang , a fifth-year doctoral student in the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), has been awarded the 2021 Chairman’s Prize. The competitive award is presented annually and was established by GSK’s Board of Trustees Chair Louis

During the upcoming ASCO Virtual Scientific Program, MSK Chief of Thoracic Oncology Service Charles M. Rudin, MD, PhD, will present a study that found pembrolizumab addition to first-line chemotherapy significantly improved progression-free survival for patients with small cell lung cancer (SCLC).

… Thursday, May 28, 2020 Dr. Charles Rudin Dr. Charles Rudin At the American Society of Clinical Oncology (ASCO) Virtual Scientific Program , Memorial Sloan Kettering (MSK) Chief of Thoracic Oncology Service Charles M. Rudin, MD, PhD , will present a study that found pembrolizumab addition to first-line

Investigators have created the first-ever genetically engineered model of cancer made from human embryonic stem cells in culture.

… Monday, December 1, 2014 Summary Investigators have created the first-ever genetically engineered model of cancer made from human embryonic stem cells in culture. Since the late 1990s, when researchers first reported a technique to isolate and grow human embryonic stem cells, known as ES cells, in culture

Learn about diversity and inclusion at Memorial Sloan Kettering, as people from across MSK share their insights and personal experiences.

… Thursday, October 1, 2020 Memorial Sloan Kettering is committed to having conversations about discrimination, diversity, and inclusion, and creating change. People from across MSK share their personal experiences and insights. Louis Voigt Louis Voigt LOUIS VOIGT Associate Attending Department of Anesthesiology

An international study led by researchers at Memorial Sloan Kettering Cancer Center has identified genetic variants in women with BRCA2 mutations that may increase or decrease their risk of developing breast cancer.

… Thursday, October 28, 2010 An international study led by researchers at Memorial Sloan Kettering Cancer Center has identified genetic variants in women with BRCA2 mutations that may increase or decrease their risk of developing breast cancer . The study was published today online in the open-access journal

GSK congratulates ten of its doctoral students who have been recognized by esteemed organizations for their promising academic research.

… Thursday, October 8, 2020 The Gerstner Sloan Kettering (GSK) Graduate School of Biomedical Sciences congratulates ten of its doctoral students — eight of them women — who have been recognized by esteemed organizations for their promising academic research. They each will receive stipend awards to support

Learn about a blood test using carbon nanotubes that could potentially detect brain tumors.

… Thursday, January 8, 2026 Imagine a blood test that detects the first signs of a  brain tumor when it might be treated more easily. A liquid biopsy for brain cancers is now one step closer to reality. The laboratory of  Memorial Sloan Kettering Cancer Center (MSK) biomedical engineer Daniel Heller, PhD

Learn about how the Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center supports MSK researchers as they learn more about the number one problem in cancer research today.

… Thursday, July 1, 2021 Alan Gerry has always recognized an opportunity when he sees one. His parents both emigrated from Russia to New York City in their youth so their families could build better lives. They met while working in a garment factory on the Lower East Side and soon married and had three